Outlook Therapeutics to Present at the RANZCO 52nd Annual Scientific Congress
Pivotal Phase 3 data from the NORSE TWO registration trial to be presented by Lawrence…
Month: February 2022
Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022
Ceremony Recognizes Importance of Biopharma Industry and Advocacy Group Collaboration to Address Needs for New…
Codex DNA to Present at the Cowen 42nd Annual Healthcare Conference
SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
Pliant Therapeutics to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Oncotelic Presenting at BiotechGate Digital Partnering
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-β OT-101 has completed over six clinical trials against…
Berkeley Lights Reports Fourth Quarter and Full Year 2021 Financial Results
Reports full year 2021 revenue of $85.4 million, above pre-announced preliminary range Reiterates 2022 revenue…
Vaccinex, Inc. to Present at CHDI’s 17th Annual HD Therapeutics Conference Meeting
Poster Presentation: Combination immunotherapy and HTT-lowering in humanized HD mice, Wednesday, March 2, 2022 ROCHESTER,…
Clarus Announces Strategic Partnerships for JATENZO® (testosterone undecanoate) with Vault Health and AssistRx – Leaders in Providing Healthcare Services to Patients
JATENZO is the first and only FDA-approved oral softgel capsule for testosterone replacement therapy in…
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
FORT LAUDERDALE, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
SEATTLE and VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Fulcrum Therapeutics® to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on Thursday, March 3, 2022 at 8:00 a.m. ET
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company…
89bio Announces Appointment of E. Morrey Atkinson, Ph.D., to its Board of Directors
SAN FRANCISCO, Feb. 24, 2022 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
Madrigal Pharmaceuticals Provides Business and Clinical Updates and Reports 2021 Fourth Quarter and Full Year Financial Results
CONSHOHOCKEN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical…
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
Fourth Quarter Highlights: Consolidated Net Revenue of $14 Million Up 15% vs. Third Quarter of…
Immutep to Present at Healthcare Investor Conferences
SYDNEY, AUSTRALIA, Feb. 24, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or…
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström Syndrome
— FDA sets updated PDUFA goal date of June 16, 2022 — — Company also…
HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research
The naturally derived GMP psilocybin will be exported through distribution partner Mycrodose Therapeutics Inc. to…
Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance
Full-Year 2021 Total Revenue Growth of 26% Full-Year 2022 Total Revenue Guidance of $178 to…
Science 37®’s Operating System Receives ISO Certification for Information Security Management
ISO 27001 certification and ISO 27701:2019 extension demonstrate Science 37’s commitment to quality, cybersecurity and…
Genenta to Participate at Upcoming Investor Conferences
MILAN, Italy and NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA),…